当前位置： SCI文献检索 > JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY期刊下所有文献 > Cost of atopic dermatitis and eczema in the United States.

Cost of atopic dermatitis and eczema in the United States.

Abstract：

BACKGROUND:Atopic dermatitis/eczema (AD/E) is a common disease. Few studies have attempted to quantify the cost to third-party payers. OBJECTIVE:Our purpose was to identify the annual cost of medical services and prescription drugs for the treatment of AD/E to private insurance and Medicaid payers in the United States. METHODS:We used a retrospective study design employing claims data from 1997 and 1998 from a private insurer and a state Medicaid program to analyze costs incurred. Beneficiaries were considered to have AD/E if they had at least one claim in 1997 with a primary or secondary listing of 1 of 3 diagnosis codes: 691.8, other atopic dermatitis and related conditions; 692.9, contact dermatitis and other eczema when no cause is specified; or 373.3, noninfectious dermatoses of eyelid. Patients who did not meet the diagnosis criteria served as a control group in each payer for comparisons of expenditures with the AD/E group. RESULTS:Disease prevalence was 2.4% (private insurer) to 2.6% (Medicaid) of all eligible beneficiaries, and 3.5% to 4.1% of patients submitted at least one health care claim during the study period. Medicaid-insured patients used outpatient hospital visits and hospitalizations at a greater rate than did privately insured patients; neither used emergency departments extensively. The third-party payer cost of illness for AD/E ranged from $0.9 billion to $3.8 billion when projected across the total number of persons younger than 65 years insured by private insurers and Medicaid in the United States. More than one fourth of all health care costs for patients with AD/E may be attributed to AD/E and co-morbid conditions. CONCLUSIONS:Annual costs of AD/E are similar to those of other diseases such as emphysema, psoriasis, and epilepsy. Patients incur significant costs associated with AD/E and co-morbid conditions.

journal_name

J Am Acad Dermatol

journal_title

Journal of the American Academy of Dermatology

authors

Ellis CN,Drake LA,Prendergast MM,Abramovits W,Boguniewicz M,Daniel CR,Lebwohl M,Stevens SR,Whitaker-Worth DL,Cheng JW,Tong KB

doi

10.1067/mjd.2002.120528

subject

Has Abstract

pub_date

2002-03-01 00:00:00

pages

361-70

issue

eissn

0190-9622

issn

1097-6787

pii

S0190-9622(02)97717-0

journal_volume

pub_type

杂志文章

在线工具

Cost of atopic dermatitis and eczema in the United States.